Rheumatoid Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
In addition, the most frequently examined CAMs to predict response to treatment were vascular cell adhesion molecule-1 (VCAM-1, n = 2) in SLE, and intercellular adhesion molecule-1 (ICAM-1, n = 12), VCAM-1 (n = 12), and E-selectin (n = 14) in RA.
|
31820195 |
2020 |
Rheumatoid Arthritis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
VLA4 expression was significantly downregulated on CD3+ T cells, CD56+ NK cells, and CD3+/CD56+ NK-T cells from PD patients; further, an increase of the soluble VLA4 ligand VCAM1 in patient plasma was noted. sVCAM1 in PD patients was even higher than reported for patients with multiple sclerosis, neuromyelitis optica, and rheumatoid arthritis. sVCAM1 levels correlated with the disease stage (Hoehn and Yahr scale) and motor impairment.
|
31068198 |
2019 |
Rheumatoid Arthritis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
OA FLS and RA FLS expressed a similar profile of cell surface antigens, including the fibroblast markers VCAM1 and ICAM1.
|
31812161 |
2019 |
Rheumatoid Arthritis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Our results showed that ICAM-1 and VCAM-1 levels were positively correlated with CRT levels in RA serum and synovial fluid, respectively.
|
30639474 |
2019 |
Rheumatoid Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Patients belonged to three main entities: rheumatoid arthritis (RA, <i>n</i> = 32), collagen diseases (CD, <i>n</i> = 56) also including systemic sclerosis (SSc, <i>n</i> = 11), and other autoimmune diseases (<i>n</i> = 12). sICAM-1 was similar among groups. sELAM-1 was elevated by 1.9-fold in only in SSc. sVCAM-1 was elevated by 3.1-fold in RA and by 3.3-fold in CD and in other autoimmune diseases by 3.4-fold.
|
29487871 |
2018 |
Rheumatoid Arthritis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Our data show that lower levels of VCAM-1 are associated with RA independently of MetS, while increased PAI-1 levels were associated with both RA and MetS and increased selectins (E-selectin and P-selectin) were exclusively associated with MetS and not with RA.
|
30008151 |
2018 |
Rheumatoid Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
In RA disease, the use of NCL as adjuvant with ETN has resulted in a marked reduction in clinical assessment scoring indices and significantly decreased the E-selectin, ICAM-1, and VCAM-1 with marked improvement in the quality of life of patients.
|
29882203 |
2018 |
Rheumatoid Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Recent evidence suggests that VCAM-1 is closely associated with the progression of various immunological disorders, including rheumatoid arthritis, asthma, transplant rejection, and cancer.
|
29614819 |
2018 |
Rheumatoid Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Therefore, single nucleotide polymorphisms of 14 genes involved in cellular adhesion processes (CAST, ITGA4, ITGB1, ITGB2, PECAM1, PTEN, PTPN11, PTPRC, PXN, SELE, SELP, SRC, TYK2, and VCAM1) were analyzed for association with RA.
|
25147926 |
2014 |
Rheumatoid Arthritis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Largazole, a class I histone deacetylase inhibitor, enhances TNF-α-induced ICAM-1 and VCAM-1 expression in rheumatoid arthritis synovial fibroblasts.
|
23632129 |
2013 |
Rheumatoid Arthritis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Involvement of MAPKs and NF-kappaB in tumor necrosis factor alpha-induced vascular cell adhesion molecule 1 expression in human rheumatoid arthritis synovial fibroblasts.
|
20039412 |
2010 |
Rheumatoid Arthritis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Moreover, an additive or synergistic effect was observed in the combined treatment of IL-27 and TNF-α or IL-1 β on the surface expression of ICAM-1 and VCAM-1 and the release of CXCL9 and CXCL10 of RA-FLS.
|
20604932 |
2010 |
Rheumatoid Arthritis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Expression of ICAM1 and VCAM1 serum levels in rheumatoid arthritis clinical activity. Association with genetic polymorphisms.
|
19597294 |
2009 |
Rheumatoid Arthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
The VCAM-1/very late activation antigen 4 adhesive system critically mediates EPC adhesion to cultured RA fibroblasts and to RA ST cryosections.
|
17530710 |
2007 |
Rheumatoid Arthritis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Vascular cell adhesion molecule-1 (VCAM-1, CD106) is important in leukocyte trafficking and its increased expression is associated with a number of chronic inflammatory diseases, including rheumatoid arthritis (RA).
|
17922685 |
2007 |
Rheumatoid Arthritis
|
0.100 |
AlteredExpression
|
disease |
LHGDN |
Soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) in patients with early rheumatoid arthritis.
|
17963163 |
2007 |
Rheumatoid Arthritis
|
0.100 |
AlteredExpression
|
disease |
LHGDN |
The role of vascular cell adhesion molecule 1/ very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium.
|
17530710 |
2007 |
Rheumatoid Arthritis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Human dermal microvascular endothelial cell (HDMEC) and RA synovial fibroblast (RASF) proliferation and intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) expression were assessed by a bromodeoxyuridine proliferation assay and flow cytometry.
|
17009243 |
2006 |
Rheumatoid Arthritis
|
0.100 |
AlteredExpression
|
disease |
LHGDN |
Strong LFA-1 and VCAM-1 expression in histological type II of rheumatoid arthritis.
|
12643440 |
2002 |
Rheumatoid Arthritis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Proinflammatory cytokines (IL-1beta: 58 +/- 9 versus 22 +/- 10; TNF-alpha: 41 +/- 6 versus 11 +/- 3; IL-8: 59 +/- 12 versus 29 +/- 9; treated versus untreated), adhesion molecule (ICAM-1: 57 +/- 11 versus 29 +/- 15; VCAM-1: 49 +/- 7 versus 21 +/- 13; treated versus untreated) as well as Cox-1 (59 +/- 10 versus 20 +/- 3) expression was down-regulated in RA synovium treated.
|
12296865 |
2002 |
Rheumatoid Arthritis
|
0.100 |
AlteredExpression
|
disease |
LHGDN |
Signal transduction pathways involved in rheumatoid arthritis synovial fibroblast interleukin-18-induced vascular cell adhesion molecule-1 expression.
|
12105209 |
2002 |
Rheumatoid Arthritis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
32 fresh cryo-conserved RA-SM (type I, II, III; n = 9, 11, 12, respectively) were investigated immunohistochemically using the APAAP method in order to obtain the expression of LFA-1, VCAM-1, CD44 and E-selectin.
|
12643440 |
2002 |
Rheumatoid Arthritis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Protection of B cells from apoptosis and up-regulation of Bcl-xL by RA SCL were both blocked by mAbs to CD106 (VCAM-1), but not CD54 (ICAM-1).
|
10623863 |
2000 |
Rheumatoid Arthritis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
These results indicate that the adhesion of RA synovial cells to matrices such as hyaluronic acid through CD44 could up-regulate VCAM-1 expression and VCAM-1-mediated adhesion to T cells, which might in turn cause activation of T cells and synovial cells in RA synovitis.
|
9973520 |
1999 |
Rheumatoid Arthritis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Thus, our data show that IL-8, IL-10, ICAM-1 and VCAM-1 expression levels are higher in synovial tissue from patients with RA than in similar tissue from patients with OA.
|
10447928 |
1999 |